Catalyst Wire Dossier Catalyst Wire Dossier

GOREISAN

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GOREISAN, covering 2026-01-06 to 2026-01-06. Get the full timeline:

Most recent: Clinical Trial Update: GOREISAN for Heart Failure (GOREISAN-HF) Trial [Phase 4]

See pricing